Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Disease overview

Viral

Murray Valley encephalitis virus infection

墨累谷脑炎病毒感染

Follow this disease Compare countries
Evidence-backed information EN 5/7 applicable sections · ZH 5/7 applicable sections Updated Oct 23, 2026

Murray Valley encephalitis virus (MVEV) is a mosquito-borne zoonotic flavivirus endemic to northern Australia and Papua New Guinea, where it is maintained in a bird–mosquito–bird cycle with waterbirds as reservoirs and Culex annulirostris as the principal vector [1][2][3]. Although endemic to the north, the virus has periodically caused substantial human outbreaks in south-eastern Australia when heavy summer rainfall and flooding of the Murray–Darling system allow spread to southern states, with epidemics separated by decades [3]. Most human infections are subclinical, but the small proportion that progresses to Murray Valley encephalitis can produce permanent neurological disease or death, making it a notable public health concern in receptive regions [1][3].

Read the full clinical and epidemiological profile 6
Definition

Murray Valley encephalitis virus (MVEV) is a zoonotic flavivirus endemic to northern Australia and Papua New Guinea, and the causative agent of Murray Valley encephalitis (formerly known as Australian encephalitis or Australian X disease) [1][3]. It is closely related to Kunjin virus, sharing similar ecology but typically causing higher morbidity [3]. Human infection is acquired exclusively through the bite of an infected mosquito, as the virus is not transmitted from person to person [3].

Clinical features

The great majority of MVEV infections are asymptomatic, with serological surveys indicating that only about one in 800–1000 infections results in clinical disease [3]. A minority of those infected experience a mild illness with fever, headache, nausea and vomiting, and only a small fraction of these progress to encephalitis [3]. When Murray Valley encephalitis develops, it can cause permanent neurological damage or death, and infection is believed to confer lifelong immunity thereafter [3].

Epidemiology

MVEV is endemic to northern Australia and Papua New Guinea, with occasional southward incursions into south-eastern Australia during heavy summer monsoon rainfall and Murray–Darling River flooding, producing outbreaks separated by decades of very few or no identified cases [3]. Historical epidemics were recorded in 1917 and 1918 in south-eastern Australia following high-rainfall years, and the virus was first isolated from humans during a 1951 Murray Valley epidemic [3]. In Victoria during the 2022–2023 mosquito season, integrated surveillance detected MVEV in mosquitoes on 48 occasions across more than 3,000 trapping events and identified 6 confirmed human cases alongside additional unspecified flavivirus infections, with one probable equine case detected through enhanced animal surveillance [1]. Other endemic Australian mosquito-borne viruses such as Ross River and Barmah Forest viruses are reviewed together with MVEV in describing the country's zoonotic arboviral landscape [4].

Transmission

MVEV is maintained in an enzootic bird–mosquito–bird cycle, with waterbirds of the order Ciconiiformes—including herons and cormorants—serving as the natural reservoir [3]. The principal mosquito vector is Culex annulirostris, and spread to southern Australia is thought to occur when infected birds or mosquitoes migrate from endemic northern regions during flood conditions [3]. Humans and horses are incidental, dead-end hosts; human infection occurs only through the bite of an infected mosquito, and person-to-person transmission does not occur [3].

Prevention

Effective prevention of flavivirus infections depends on interrupting the principal transmission route, which is arthropod-borne via mosquito or tick vectors, together with targeted vaccination where vaccines are available. For mosquito-borne flaviviruses such as dengue, transmission occurs between humans and Aedes mosquitoes, so vector control measures aimed at reducing Aedes populations and limiting human–vector contact are central to prevention [2]. Japanese encephalitis virus, the most important cause of epidemic encephalitis and a flavivirus whose geographical area continues to expand, can be prevented through vaccination, which is available for at-risk populations, as well as through personal protection against mosquito bites and broader vector management; the availability of vaccines, despite ongoing geographical expansion of the virus, supports the feasibility of this combined approach [2]. For tick-borne flaviviruses such as tick-borne encephalitis virus, which occurs across large parts of Eastern Europe and the Commonwealth of Independent States, prevention strategies focus on avoiding tick bites, including the use of protective clothing, repellents, and tick checks, together with vaccination of at-risk groups living in or travelling to endemic areas [2]. Yellow fever, an arboviral haemorrhagic disease that resurged in the late 20th century after mid-century control, is preventable through vaccination, which has historically been the cornerstone of preventing outbreaks, alongside continued surveillance and vector control in affected regions [2]. Taken together, prevention of flavivirus disease rests on three complementary pillars: (1) vector control to reduce populations of mosquitoes such as Aedes or to reduce exposure to ticks in endemic areas; (2) personal protective measures to minimize bites by infected arthropods; and (3) vaccination where an effective vaccine exists, notably for Japanese encephalitis and yellow fever [2].

References
  1. 1 Braddick M et al. An integrated public health response to an outbreak of Murray Valley encephalitis virus infection during the 2022-2023 mosquito season in Victoria. Front Public Health. 2023. PMID: 37860808. doi: 10.3389/fpubh.2023.1256149. PubMed: https://pubmed.ncbi.nlm.nih.gov/37860808/
  2. 2 Solomon T et al. Dengue and other emerging flaviviruses. J Infect. 2001 Feb. PMID: 11531316. doi: 10.1053/jinf.2001.0802. PubMed: https://pubmed.ncbi.nlm.nih.gov/11531316/
  3. 3 Wikipedia contributors. Murray Valley encephalitis virus - Wikipedia [Internet]. Wikipedia. cited 3 Sept 2026. Available from: https://en.wikipedia.org/wiki/Murray_Valley_encephalitis_virus
  4. 4 Ong OTW et al. Mosquito-Borne Viruses and Non-Human Vertebrates in Australia: A Review. Viruses. 2021 Feb 9. PMID: 33572234. doi: 10.3390/v13020265. PubMed: https://pubmed.ncbi.nlm.nih.gov/33572234/
Coding Register
ICD-10
ICD-11
Data coverage

Loading current data…

Country surveillance trends

Choose a country, source, and measure. Each line retains its published reporting period and definition.

Loading data…

Coverage

Reporting countries and regions

The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.

Loading current data…

Surveillance pattern

Year × month seasonality by country

Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.

Loading official alerts…

Downloads and methods

Choose a time range and download CSV, JSON or XLSX files.

Partitioned public data

Choose a time range and format

Download archives have their own release date and may differ from the live curves.